These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Hepatic hemodynamics in 24 patients with nodular regenerative hyperplasia and symptomatic portal hypertension. Bissonnette J; Généreux A; Côté J; Nguyen B; Perreault P; Bouchard L; Pomier-Layrargues G J Gastroenterol Hepatol; 2012 Aug; 27(8):1336-40. PubMed ID: 22554152 [TBL] [Abstract][Full Text] [Related]
5. Nodular regenerative hyperplasia of the liver. A review of 14 cases. Arvanitaki M; Adler M Hepatogastroenterology; 2001; 48(41):1425-9. PubMed ID: 11677979 [TBL] [Abstract][Full Text] [Related]
6. Nodular regenerative hyperplasia of the liver: an under-recognized cause of portal hypertension in hematological disorders. Al-Mukhaizeem KA; Rosenberg A; Sherker AH Am J Hematol; 2004 Apr; 75(4):225-30. PubMed ID: 15054815 [TBL] [Abstract][Full Text] [Related]
7. Nodular regenerative hyperplasia of liver--a rare cause of portal hypertension in patients of rheumatoid arthritis. Agasti AK; Jignesh P; Vashisth C; Samarth A; Ravinder G; Sawan P J Assoc Physicians India; 2011 Sep; 59():589-91. PubMed ID: 22334975 [TBL] [Abstract][Full Text] [Related]
8. Nodular regenerative hyperplasia is a new cause of chronic liver disease in HIV-infected patients. Mallet V; Blanchard P; Verkarre V; Vallet-Pichard A; Fontaine H; Lascoux-Combe C; Pol S AIDS; 2007 Jan; 21(2):187-92. PubMed ID: 17197809 [TBL] [Abstract][Full Text] [Related]
9. Combined granulomatous slack skin/folliculotropic mycosis fungoides: case report. Chen J; Chen G; Mao X; Li X; Li B; Lao L Int J Dermatol; 2013 Nov; 52(11):1441-5. PubMed ID: 22320384 [No Abstract] [Full Text] [Related]
10. Nodular regenerative hyperplasia of the liver: a case report. Doğan E; Ozgür R; Ercan V; Tekin A; Senkal O; Cevikbaş U Turk J Gastroenterol; 2003 Mar; 14(1):64-7. PubMed ID: 14593541 [TBL] [Abstract][Full Text] [Related]
12. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers. Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969 [TBL] [Abstract][Full Text] [Related]
13. Hepatocellular carcinoma arising in primary biliary cirrhosis presenting with nodular regenerative hyperplasia: report of an autopsy case. Sasaki M; Hodo Y; Nakanuma Y J Gastroenterol Hepatol; 2006 Dec; 21(12):1866-8. PubMed ID: 17074034 [No Abstract] [Full Text] [Related]
14. Mild changes of hepatic nodular regenerative hyperplasia may cause portal hypertension and be visible on reticulin but not hematoxylin and eosin staining. Navale P; Gonzalez RS Virchows Arch; 2021 Dec; 479(6):1145-1152. PubMed ID: 34435237 [TBL] [Abstract][Full Text] [Related]
15. Intrahepatic portal venopathy and related disorders of the liver. Chawla Y; Dhiman RK Semin Liver Dis; 2008 Aug; 28(3):270-81. PubMed ID: 18814080 [TBL] [Abstract][Full Text] [Related]
17. Nodular regenerative hyperplasia and severe portal hypertension in cystinosis. O'Brien K; Hussain N; Warady BA; Kleiner DE; Kleta R; Bernardini I; Heller T; Gahl WA Clin Gastroenterol Hepatol; 2006 Mar; 4(3):387-94. PubMed ID: 16527704 [TBL] [Abstract][Full Text] [Related]
18. Hepatic nodular regenerative hyperplasia in a patient with advanced carcinoid tumor. Al-Hamoudi WK; Pasieka JL; Urbanski SJ; Lee SS Eur J Gastroenterol Hepatol; 2009 Sep; 21(9):1083-5. PubMed ID: 19318967 [TBL] [Abstract][Full Text] [Related]
19. Nodular regenerative hyperplasia: evolving concepts on underdiagnosed cause of portal hypertension. Hartleb M; Gutkowski K; Milkiewicz P World J Gastroenterol; 2011 Mar; 17(11):1400-9. PubMed ID: 21472097 [TBL] [Abstract][Full Text] [Related]
20. Hepatic encephalopathy as an unusual late complication of transjugular intrahepatic portosystemic shunt insertion for non-cirrhotic portal hypertension caused by nodular regenerative hyperplasia in an HIV-positive patient on highly active antiretroviral therapy. Ding A; Lee A; Callender M; Loughrey M; Quah SP; Dinsmore WW Int J STD AIDS; 2010 Jan; 21(1):71-2. PubMed ID: 20029067 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]